DE69325366D1 - Verfahren zur hautpflege und mittel - Google Patents

Verfahren zur hautpflege und mittel

Info

Publication number
DE69325366D1
DE69325366D1 DE69325366T DE69325366T DE69325366D1 DE 69325366 D1 DE69325366 D1 DE 69325366D1 DE 69325366 T DE69325366 T DE 69325366T DE 69325366 T DE69325366 T DE 69325366T DE 69325366 D1 DE69325366 D1 DE 69325366D1
Authority
DE
Germany
Prior art keywords
agent
skin care
composition
component
skin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69325366T
Other languages
English (en)
Other versions
DE69325366T2 (de
Inventor
Anthony Vincent Rawlings
Ian Richard Scott
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Unilever NV
Original Assignee
Unilever NV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Unilever NV filed Critical Unilever NV
Publication of DE69325366D1 publication Critical patent/DE69325366D1/de
Application granted granted Critical
Publication of DE69325366T2 publication Critical patent/DE69325366T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00Preparations for care of the hair
    • A61Q5/006Antidandruff preparations
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46Hydrolases (3)
    • A61K38/465Hydrolases (3) acting on ester bonds (3.1), e.g. lipases, ribonucleases
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46Hydrolases (3)
    • A61K38/47Hydrolases (3) acting on glycosyl compounds (3.2), e.g. cellulases, lactases
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46Hydrolases (3)
    • A61K38/48Hydrolases (3) acting on peptide bonds (3.4)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64Proteins; Peptides; Derivatives or degradation products thereof
    • A61K8/66Enzymes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/007Preparations for dry skin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Dermatology (AREA)
  • Birds (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Cosmetics (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DE69325366T 1992-04-02 1993-03-31 Verfahren zur hautpflege und mittel Expired - Fee Related DE69325366T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB929207280A GB9207280D0 (en) 1992-04-02 1992-04-02 Skin care method and composition
PCT/GB1993/000665 WO1993019731A1 (en) 1992-04-02 1993-03-31 Skin care method and composition

Publications (2)

Publication Number Publication Date
DE69325366D1 true DE69325366D1 (de) 1999-07-22
DE69325366T2 DE69325366T2 (de) 1999-11-04

Family

ID=10713365

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69325366T Expired - Fee Related DE69325366T2 (de) 1992-04-02 1993-03-31 Verfahren zur hautpflege und mittel

Country Status (14)

Country Link
US (1) US5439935A (de)
EP (1) EP0633764B1 (de)
JP (1) JPH07505383A (de)
KR (1) KR950700722A (de)
AT (1) ATE181231T1 (de)
AU (1) AU675426B2 (de)
BR (1) BR9306178A (de)
CA (1) CA2133085A1 (de)
DE (1) DE69325366T2 (de)
ES (1) ES2132227T3 (de)
GB (1) GB9207280D0 (de)
GR (1) GR3031016T3 (de)
WO (1) WO1993019731A1 (de)
ZA (1) ZA932403B (de)

Families Citing this family (68)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9207288D0 (en) * 1992-04-02 1992-05-13 Unilever Plc Cosmetic composition
US6030612A (en) * 1994-11-22 2000-02-29 Phairson Medical Inc. Antimicrobial uses of multifunctional enzyme
US5945102A (en) * 1994-11-22 1999-08-31 Phairson Medical Inc. Crustacean and fish derived multifunctional enzyme
US5958406A (en) * 1994-11-22 1999-09-28 Phairson Medical Inc. Acne treatment with multifunctional enzyme
US7947270B2 (en) * 1992-05-22 2011-05-24 Arcimboldo Ab Removing dental plaque with krill enzymes
US20060134641A1 (en) * 1992-05-22 2006-06-22 Franklin Richard L Treating viral infections with krill enzymes
IT1270951B (it) * 1993-06-07 1997-05-26 Boehringer Mannheim Italia Metodo e dispositivo per il rilevamento simultano di neisseria gonorrhoeae, chlamydia trachomatis e mycoplasma
EP0719133A1 (de) * 1993-09-15 1996-07-03 Unilever Plc Hautpflegeverfahren und zusammensetzung
GB9319103D0 (en) * 1993-09-15 1993-11-03 Unilever Plc Skin care method & composition
FR2721210B1 (fr) * 1994-06-17 1996-08-02 Oreal Composition de nettoyage contenant des grains lipidiques.
FR2725898B1 (fr) * 1994-10-24 1996-12-13 Oreal Produit pour application topique contenant une lipase et un precurseur d'hydroxyacide
FR2729079A1 (fr) * 1995-01-09 1996-07-12 Sederma Sa Nouvelles compositions cosmetiques contenant des ceramides et autres lipides complexes
US6232088B1 (en) 1995-02-08 2001-05-15 Phairson Medical, Inc. Treatment and prevention of immune rejection reactions
FR2732593B1 (fr) * 1995-04-04 1997-05-23 Bieurope Compositions cosmetiques a base d'enzymes proteases ou beta-glucosidases immobilisees pour favoriser l'elimination des cellules superficielles de la peau
DE19600480A1 (de) * 1996-01-09 1997-07-10 Beiersdorf Ag Verwendung von Serin-Proteinasen gegen Akne und entzündete Comedonen
US6407056B1 (en) * 1996-07-12 2002-06-18 Johnson & Johnson Consumer Companies, Inc. Methods for altering hair growth and hair pigmentation by apoptosis in the follicular papillae and compositions therefor
US5776461A (en) * 1996-07-26 1998-07-07 Chesebrough-Pond's Usa Co., Division Of Conopco, Inc. Cosmetic compositions containing phytovitamin D
DE19649098A1 (de) * 1996-11-27 1998-05-28 Beiersdorf Ag Antiadhäsive Proteasen
DE19649096A1 (de) * 1996-11-27 1998-05-28 Beiersdorf Ag Antiadhäsive Glycosidasen
DE19649097A1 (de) * 1996-11-27 1998-05-28 Beiersdorf Ag Antiadhäsive Lipasen
US5811112A (en) * 1997-05-30 1998-09-22 Chesebrough-Pond's Usa Co., Division Of Conopco Inc. Oil-in-water cosmetic emulsions containing a stabilized protease
US6284246B1 (en) 1997-07-30 2001-09-04 The Procter & Gamble Co. Modified polypeptides with high activity and reduced allergenicity
US6908757B1 (en) 1998-03-26 2005-06-21 The Procter & Gamble Company Serine protease variants having amino acid deletions and substitutions
US6495136B1 (en) 1998-03-26 2002-12-17 The Procter & Gamble Company Proteases having modified amino acid sequences conjugated to addition moieties
JP2002507426A (ja) 1998-03-26 2002-03-12 ザ、プロクター、エンド、ギャンブル、カンパニー アミノ酸置換を有するセリンプロテアーゼ変異体
DE19824073A1 (de) * 1998-05-29 1999-12-02 Beiersdorf Ag Kosmetische und dermatologische Zubereitungen mit einem wirksamen Gehalt an immobilisierten oder freien Lipasen, die die Viskosität von Hautfett beeinflussen
DE19829789A1 (de) * 1998-07-03 2000-01-05 Beiersdorf Ag Gegen Akne und entzündete Comedonen wirksame Zubereitungen enthaltend Serin-Proteasen und ein oder mehrere Calciumsalze
US6217852B1 (en) 1998-08-15 2001-04-17 Skinnovative Dermatologic Concepts, L.L.C. Personal cleansing compositions having photoprotective agents
AU5928100A (en) 1999-07-22 2001-02-13 Procter & Gamble Company, The Subtilisin protease variants having amino acid deletions and substitutions in defined epitope regions
US6946128B1 (en) 1999-07-22 2005-09-20 The Procter & Gamble Company Protease conjugates having sterically protected epitope regions
MXPA02000840A (es) 1999-07-22 2002-07-30 Procter & Gamble Variantes de proteasa de subtilisina que tienen substituciones de aminoacidos en regiones de epitopes definidas.
CZ2002171A3 (cs) 1999-07-22 2002-06-12 The Procter & Gamble Company Proteinázový konjugát, čistící prostředek a prostředek osobní péče
US6642038B1 (en) 1999-09-14 2003-11-04 Genzyme Glycobiology Research Institute, Inc. GlcNAc phosphotransferase of the lysosomal targeting pathway
US6770468B1 (en) 1999-09-14 2004-08-03 Genzyme Glycobiology Research Institute, Inc. Phosphodiester-α-GlcNAcase of the lysosomal targeting pathway
US6632429B1 (en) 1999-12-17 2003-10-14 Joan M. Fallon Methods for treating pervasive development disorders
DE10025720C2 (de) * 2000-05-25 2002-05-29 Walterscheid Gmbh Gkn Antriebsanordnung mit Freilaufkupplung
US20070053895A1 (en) * 2000-08-14 2007-03-08 Fallon Joan M Method of treating and diagnosing parkinsons disease and related dysautonomic disorders
MXPA03002166A (es) * 2000-09-13 2003-07-24 Procter & Gamble Metodo cosmetico para tratar la piel y/o el cabello.
US8030002B2 (en) 2000-11-16 2011-10-04 Curemark Llc Methods for diagnosing pervasive development disorders, dysautonomia and other neurological conditions
US8092834B2 (en) * 2001-06-29 2012-01-10 Shiseido Co., Ltd. Composite powders and skin preparations for external use containing the same
US20030124652A1 (en) * 2001-12-21 2003-07-03 Novazyme Pharmaceuticals, Inc. Methods of producing high mannose glycoproteins in complex carbohydrate deficient cells
US6905856B2 (en) 2001-12-21 2005-06-14 Genzyme Glycobiology Research Institute, Inc. Soluble GlcNAc phosphotransferase
US6800472B2 (en) * 2001-12-21 2004-10-05 Genzyme Glycobiology Research Institute, Inc. Expression of lysosomal hydrolase in cells expressing pro-N-acetylglucosamine-1-phosphodiester α-N-acetyl glucosimanidase
US20030198631A1 (en) * 2002-04-18 2003-10-23 Healthpoint, Ltd. Thermolysin enzymatic wound debrider
US6835385B2 (en) * 2002-06-14 2004-12-28 Carol J. Buck Compositions and methods for softening, thinning and removing hyperkeratotic tissue
DE10237317B4 (de) * 2002-08-15 2010-04-08 3M Espe Ag Enzymhaltige Zusammensetzung, Verfahren zu deren Herstellung und deren Verwendung
EP1600141B1 (de) * 2004-05-24 2013-04-17 3M Deutschland GmbH Zusammensetzungen mit kollagenolytisch aktivem Enzym zur Behandlung von Karies
MX2007011486A (es) * 2005-03-24 2007-11-20 Anacor Pharmaceuticals Inc Formulaciones topicas de antibioticos de acido borinico y sus metodos de uso.
EP1754464A1 (de) * 2005-08-17 2007-02-21 3M Innovative Properties Company Enzym-haltige Zusammensetzung für den dentalen Gebrauch
US20080058282A1 (en) 2005-08-30 2008-03-06 Fallon Joan M Use of lactulose in the treatment of autism
EP2217266A2 (de) * 2007-11-06 2010-08-18 Kristian Hellgren Verfahren zur behandlung von erkrankungen der mundhöhle mit einer krillenzym-zusammensetzung
US8658163B2 (en) * 2008-03-13 2014-02-25 Curemark Llc Compositions and use thereof for treating symptoms of preeclampsia
US8084025B2 (en) 2008-04-18 2011-12-27 Curemark Llc Method for the treatment of the symptoms of drug and alcohol addiction
US20090324730A1 (en) * 2008-06-26 2009-12-31 Fallon Joan M Methods and compositions for the treatment of symptoms of complex regional pain syndrome
US9320780B2 (en) 2008-06-26 2016-04-26 Curemark Llc Methods and compositions for the treatment of symptoms of Williams Syndrome
EP2318035B1 (de) 2008-07-01 2019-06-12 Curemark, Llc Verfahren und zusammensetzungen zur behandlung von symptomen von neurologischen und geistesstörungen
US10776453B2 (en) 2008-08-04 2020-09-15 Galenagen, Llc Systems and methods employing remote data gathering and monitoring for diagnosing, staging, and treatment of Parkinsons disease, movement and neurological disorders, and chronic pain
US20100092447A1 (en) 2008-10-03 2010-04-15 Fallon Joan M Methods and compositions for the treatment of symptoms of prion diseases
KR20170005191A (ko) 2009-01-06 2017-01-11 큐어론 엘엘씨 이. 콜라이에 의한 구강 감염의 치료 또는 예방을 위한 조성물 및 방법
ES2882518T3 (es) 2009-01-06 2021-12-02 Galenagen Llc Composición que comprende proteasa, amilasa y lipasa
EP2226382A1 (de) 2009-03-03 2010-09-08 B.R.A.I.N. Biotechnology Research and Information Network AG Protease zur Wundbehandlung und Hautpflege
US9056050B2 (en) 2009-04-13 2015-06-16 Curemark Llc Enzyme delivery systems and methods of preparation and use
WO2011050135A1 (en) 2009-10-21 2011-04-28 Curemark Llc Methods and compositions for the prevention and treatment of influenza
BR112012013812A2 (pt) * 2009-12-08 2018-05-29 Healthpoint Ltd "composições para desbridamento enzimático de feridas com atividade enzimática melhorada"
ES2804223T3 (es) 2011-04-21 2021-02-04 Curemark Llc Compuestos para el tratamiento de Trastornos Neuropsiquiátricos
US10350278B2 (en) 2012-05-30 2019-07-16 Curemark, Llc Methods of treating Celiac disease
US20230233437A1 (en) * 2020-05-25 2023-07-27 Shizuoka Prefectural University Corporation Elastin production promoter and cosmetic preparation for skin
US11541009B2 (en) 2020-09-10 2023-01-03 Curemark, Llc Methods of prophylaxis of coronavirus infection and treatment of coronaviruses

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR5132M (de) * 1966-01-20 1967-06-05
FR1548652A (de) * 1967-10-27 1968-12-06
WO1984002846A1 (en) * 1983-01-21 1984-08-02 Advanced Drug Tech Enzyme ointment
US5238843A (en) * 1989-10-27 1993-08-24 Genencor International, Inc. Method for cleaning a surface on which is bound a glycoside-containing substance
DK0425016T3 (da) * 1989-10-27 1996-05-06 Genencor Int Antimikrobiel fremgangsmåde og formulering med anvendelse af type II endoglycosidase og antimikrobielt middel

Also Published As

Publication number Publication date
AU3896193A (en) 1993-11-08
JPH07505383A (ja) 1995-06-15
CA2133085A1 (en) 1993-10-14
GB9207280D0 (en) 1992-05-13
KR950700722A (ko) 1995-02-20
DE69325366T2 (de) 1999-11-04
US5439935A (en) 1995-08-08
BR9306178A (pt) 1998-06-23
AU675426B2 (en) 1997-02-06
ZA932403B (en) 1994-10-02
EP0633764A1 (de) 1995-01-18
WO1993019731A1 (en) 1993-10-14
ES2132227T3 (es) 1999-08-16
EP0633764B1 (de) 1999-06-16
GR3031016T3 (en) 1999-12-31
ATE181231T1 (de) 1999-07-15

Similar Documents

Publication Publication Date Title
DE69325366D1 (de) Verfahren zur hautpflege und mittel
DE69319231D1 (de) Verfahren zur hautpflege und mittel
ATE214933T1 (de) Dermatologische zusammensetzungen, welche benzylneroxid und ein mittel zur verminderung von hautreizungen enthalten
RU93047799A (ru) Композиции, содержащие ретиноевые кислоты и токоферол
ATE147618T1 (de) Kosmetisches und/oder dermatologisches mittel enthaltend thermal- oder mineralwasser und einen gegen akne oder älterung aktiven agentsien
NO973900L (no) Nitrogenoksyd syntase inhibitor
FI972580A (fi) Valmisteita ja menetelmiä ihoärsytyksen vähentämiseksi
PT880350E (pt) Tratamento de esclerose multipla
AU674142B2 (en) Use of cosmetic composition
DE68912195D1 (de) Verwendung von Pyrrolicloncarbonsäurealkylestern zur Herstellung eines Arzneimittels zur Behandlung von Ichtyosis.
DE69508764D1 (de) Alkoholisches feuchtigkeitsspendendes after shave lotion
DE69419981T2 (de) Retinoid enthaltendes Mittel
DE3671365D1 (de) Topische anwendung des 3-phenylacetylamino-2,6-piperidindions zur behandlung von hautfalten und hyperpigmentierung.
ATE141154T1 (de) Verfahren zur verminderung der reizenden eigenschaften von kosmetischen zusammensetzungen
ATE215810T1 (de) Abschuppungs-zusammensetzung
CA2322878A1 (en) Use of selegiline or desmethylselegiline for treating wounds, burns and dermatological damage
DE69330625D1 (de) Topisches antibakterielles Mittel
FR2782922B1 (fr) Composition contenant de l'uree et ses utilisations dans le domaine cosmetique et/ou dermatologique
GB2347625A (en) Agent for treating allergic or hypersensivity condition
DE69018570D1 (de) Wasserlösliche Vitamin A-Zubereitungen und deren Verwendung bei der Hautbehandlung.
DE59803222D1 (de) Kosmetische mittel
ATE46083T1 (de) Arzneimittel zur topischen anwendung.
BG98985U (bg) Средство за подобряване регенерацията на кожата

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee